CellCeutix: 23 Minutes with Leo Ehrlich

by DrKSSMDPhD | August 14, 2015 11:26 pm

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://sgumdev.stockgumshoe.com/2015/08/cellceutix-23-minutes-with-leo-ehrlich/


800 Comments
Inline Feedbacks
View all comments
raehepburn
7 years ago

Can you believe it. After the crazy week we’ve been through on Wall Street, I actually have a few dollars more in my account today than I had at the beginning of the week. Go figure.

๐Ÿ‘ 273
jomcintyre
jomcintyre
7 years ago
Reply to  raehepburn

Same here, Rae. Although I DID hold my breath most of the week. Also, I didn’t buy or sell anything this week. Too traumatized. That’s enough fun for the rest of the year.

๐Ÿ‘ 155
Lannas
Lannas
7 years ago
Reply to  raehepburn

Me to, mainly because Oil went up and also Reits.

Add a Topic
359
Add a Topic
2512
๐Ÿ‘ 851
Gui_
Gui_
7 years ago

Thoughts doctor, an HCV vaccine, Cambridge Biotech a legitimate contender?

(Ap0logies if this co. has already been discussed, did a cursory search)

Cambridge biotech VBI Vaccines (VBIV) developing hepatitis C vaccine gets new funding – Boston Business Journal

As several biotechs focus on developing lucrative hepatitis C drugs, a Cambridge firm developing a hepatitis C vaccine has received funding.

VBI Vaccines (Nasdaq: VBIV) has secured $6.29 million from a variety of venture capital investors, including new investor RTW Investments, with participation from ARCH Venture Partners and Perceptive Advisors.

Under the terms, VBI sold 3 million shares of stock at approximately $2 a share, resulting in the raise.

โ€œThe private placement will help strengthen VBIโ€™s balance sheet as we further our mission of innovative vaccine formulation and development of safe and effective prophylactic and therapeutic vaccines,โ€ said Jeff Baxter, VBIโ€™s president and CEO, in a release.

The raise has helped supplement a poor market performance for the company. VBI stock was trading at only $2.45 a share as of Thursday afternoon, the lowest in the companyโ€™s nearly 20-year history on the stock market. The company’s stock has fallen 23 percent since the beginning of this year.

While a spokesman said the funding is for more general research and operations, it will help the company as it develops vaccines that can withstand variations in temperature. The company is also developing vaccines for hepatitis C and cytomegalovirus โ€” a virus that can have detrimental consequences to those who are pregnant or those with weakened immune systems.

The funding is on top of $47.9 million the company secured last year, according to federal filings.

VBI is headquartered in Cambridge, with research facilities in Ottawa, Canada.

http://www.bizjournals.com/boston/blog/health-care/2015/08/cambridge-biotech-gets-funding-for-development-of.html

Also will be presenting at Rodman & Crenshaw in New York Set. 8 – 9

http://www.prnewswire.com/news-releases/rodman–renshaw-2015-annual-global-investment-conference-to-be-held-in-new-york-from-september-8-to-10-2015-300110562.html

Add a Topic
5326
Add a Topic
5326
Add a Topic
5326
๐Ÿ‘ 778
SoGiAm
7 years ago

Let’s make a move: http://www.sgumdev.stockgumshoe.com/2015/08/an-auspicious-conversation-with-aurinia-ceo-stephen-zaruby/ Have a great weekend all! Thank you ZKSS Best2ALL!-Ben

๐Ÿ‘ 11466
alanh
7 years ago

$TRVN jumps 33% after hours:
Shares of Trevena Inc. TRVN, -0.66% jumped in the extended session Monday after the drug developer announced positive results for its post-surgery pain treatment. Trevena shares surged 33% to $8. The company said a mid-stage clinical trial for its drug candidate TRV130 showed the treatment was statistically more effective at treating moderate to severe pain in patients following abdominoplasty surgery, or what is more popularly known as a “tummy tuck.”

Add a Topic
6225
๐Ÿ‘ 4086
๐Ÿ‘ 2793
Lynn Clark, Stock Gumshoe
Admin

This thread has been closed and the biotech discussions with Dr. KSS have moved to his new article. Dr. KSSโ€™s most recent article can always be found on his author page here

Add a Topic
3932
๐Ÿ‘ 151
1 11 12 13